UF Health Cancer Center
@UFHealthCancer
The NCI-designated UF Health Cancer Center blends comprehensive patient care and innovative research in a multidisciplinary environment. #WeAreNCIDesignated
Cervical cancer is the 4th most common cancer in women, but preventable when caught early. @UFHealthCancer and @LifeAtPurdue researchers are developing an at-home test using protein biomarkers to detect it faster, cheaper, and more accessibly. 🔗: innovate.research.ufl.edu/2025/06/27/at-…
A study published in @Cancers_MDPI from @UF and @LifeAtPurdue researchers paves the way for developing inexpensive, fast and accurate preliminary screening tests for cervical #cancer: ufhealth.org/news/2025/rese…
Two teams of UF Health Cancer Center researchers received pilot funding to advance cancer research with AI. One team will use AI to investigate RNA modification in tumor progression. The other will develop an AI tool for clinician communication training: go.ufl.edu/gi3f7pr
Thanks for your efforts to move research forward for patients!👏 To search cancer clinical trials at UF, visit cancer.ufl.edu/trials/.
Excited about all the Phase 3 trials and IITs launching in our UF Thoracic Oncology portfolio! Grateful to be part of a team pushing research forward for our lung cancer patients. 🚀🫁 #lcsm #LungCancer #ClinicalTrials @TGeorgeMD
UF faculty, staff, and students are propelling Florida forward with a record $1.33 billion in research — making incredible discoveries and advancements that will change the world. 👏news.ufl.edu/2025/07/resear…
Congratulations to UF Health Cancer Center member @DrMMurphy, who has been named a Fellow of @ASCO in recognition of her extraordinary volunteer service, engagement and dedication! Read more: cancer.ufl.edu/2025/07/22/mar…
Pharmacogenetics can help predict outcomes, tailor treatment, reduce disparities in AML healio.com/news/hematolog…
Discover more about this new research by Jatinder Lamba, Ph.D., co-leader of our Cancer Targeting and Therapeutics research program.⬇️
A pharmacogenetics score could help identify which patients with #AML are more likely to respond to standard cytarabine-based treatment vs. those who may not. “ACS10 score predicts outcomes,” - @LambaJK_Lab of @UF @UFPharmacy told Healio. @JAMANetworkOpen bit.ly/3GqxGoW
UF Health Cancer Center member Leighton Elliott, M.D., received a @UF Research Opportunity Seed Fund award to study how iron oxide nanoparticles may advance immunotherapy treatment. He's collaborating with Cancer Center member Carlos Rinaldi-Ramos, Ph.D. Learn more in the Q&A! ⬇️
After winning 2025 UF Research Opportunity Seed Funds (ROSF) this June, @UFMedicine investigators are already making headway on their innovative plans. Learn more about our two PI winners and their work on organ transplants and cancer immunotherapy at go.ufl.edu/snso77k.
Published in @JNanobiotech, UF Health Cancer Center researchers have developed a promising method for pancreatic cancer early detection using extracellular vesicles. Discover more in our latest Research Snapshot: go.ufl.edu/42xqwn3
Jatinder Lamba, Ph.D., co-leader of our Cancer Targeting and Therapeutics research program, led this new research on how a pharmacogenetics score can help predict outcomes and tailor treatment in AML. Learn more about the new research in this @HemOncToday article! ⬇️
🧪 Black patients with #AML generally have worse outcomes than white ones. A pharmacogenetics score could help physicians help tailor treatments to improve survival and reduce racial disparities. @LambaJK_Lab @UF @UFPharmacy @JAMANetworkOpen bit.ly/3GqxGoW
In a @VuMedi video, our clinical research fellow @AYasinzaiMD presents his new research on trends in early-onset gastrointestinal cancers from 2001-2021. Yasinzai also presented this comprehensive analysis of U.S. #cancer statistics at #ASCO25. Watch: vumedi.com/video/ascor-20…
Researchers and physician-scientists at @UF and @UFHealth are working to address some of the most pressing medical crises, including cancer, neurological disorders and antibiotic resistance. Check out some of the ways Gators are creating real-world impact: bit.ly/4kQH4k9
Honored to receive a Pediatric Research LRP award from @theNCI. Deeply thankful for the support from @NIHFunding and the outstanding mentorship at @UFRadOnc @UFHealthCancer @UFProtonTherapy . Excited to carry this work forward at @MayoRadOnc collaborating with my UF colleagues.
Don’t miss this webinar by UF Health Cancer Center member Leighton Elliott, M.D.! ⬇️
FLASCO Rare Disease Ad-Hoc Committee Presents: Advances in Treatment Options for Tenosynovial Giant Cell Tumor (TGCT) July 31, 2025 | 12:00 PM Virtual Webinar Register HERE>>lnkd.in/eu-nrbcv
Our Cancer Research Conference for Science Teachers provided an opportunity for nearly 150 science teachers to learn the latest in #cancer research, gain hands-on science skills & network. Thanks to @AstraZeneca for its sponsorship! Watch our video recap: youtube.com/watch?v=7pMdat…
💓 AYA survivors who received dexrazoxane along with their doxorubicin #chemotherapy had significant heart benefits more than a decade after treatment. Check out the findings from #ASCO25 👇 @ErinMMobley @UFJaxsurg @UFMedicineJax @UFHealthCancer @ASCO bit.ly/4lmlxQu
A research team led by UF Health Cancer Center member Ben Shen, Ph.D., created an antibody-drug combo that showed a striking ability to kill aggressive lymphomas while ignoring healthy, noncancerous cells in blood samples donated by cancer patients. ⬇️
By combining a soil microbe’s natural cancer-killing compound with an antibody, Wertheim UF Scripps scientists may have found a new approach to treating aggressive blood cancers including B cell #lymphoma. wertheim.scripps.ufl.edu/2025/07/02/ant… #drugdiscovery #cancer #cancerreseach
Glioblastoma is a nasty brain cancer with few options. @CMillerLab at @UFScripps has invented an experimental drug greenlighted for clinical trials by the @US_FDA. New papers in @CellPressNews reveal the science. Read more: wertheim.scripps.ufl.edu/2025/07/01/sci…